Study finds evidence for repurposing thiostrepton as an anti-rhabdomyosarcoma drug
Nov 24, 2025
1 min read
A research team from the Children's Hospital of Chongqing Medical University, China, reported in Pediatric Discovery that thiostrepton can significantly suppress rhabdomyosarcoma progression by targeting the PI3K-AKT signaling pathway.